Inhibrx
Biotechnology

Inhibrx news and milestones

Inhibrx: 5 headlines on record, 5 headlines in the last 90 days. Its story counts 8 milestones.

Data updated Nov 22, 2026 · Back to the company report
5Headlines
5In 90 days
8Milestones

Headlines

Sep 292026
News · YahooFinance
Inhibrx Biosciences (INBX) has drawn investor attention after a sharp move in the share price. The US$101.71 close now sits alongside a year-to-date gain of about 35%. Recent tra…
Sep 252026
News · Inhibrx Biosciences stock reports stronger cancer study data
Inhibrx Biosciences stock was priced at USD 100.40 on September 24, 2026, after Phase 2 data for INBRX-106. The study showed a 48.3 percent response rate.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Inhibrx, News. Alion, Nov 22, 2026. https://alion.io/company/inhibrx/news

.json · .md · CC BY-SA 4.0